ChemicalBook >> CAS DataBase List >>BAY 80-6946 (Copanlisib)

BAY 80-6946 (Copanlisib)

CAS No.
1032568-63-0
Chemical Name:
BAY 80-6946 (Copanlisib)
Synonyms
Copanlisib;BAY80-6946;CS-2321;Aliqopa);Copanlisib base;Copanlisib free base;Copanlisib(BAY80-6946);BAY 80-6946 (BAY80-6946;BAY 80-6946 (Copanlisib);BAY 80-6946 (Copanlisib) USP/EP/BP
CBNumber:
CB52616024
Molecular Formula:
C23H28N8O4
Molecular Weight:
480.52
MDL Number:
MFCD18633201
MOL File:
1032568-63-0.mol
MSDS File:
SDS
Last updated:2024-05-23 13:57:10

BAY 80-6946 (Copanlisib) Properties

Density 1.51
storage temp. Store at -20°C
solubility insoluble in DMSO; insoluble in H2O; insoluble in EtOH
form solid
pka 8.42±0.20(Predicted)
FDA UNII WI6V529FZ9
ATC code L01EM02

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338
NFPA 704
0
2 0

BAY 80-6946 (Copanlisib) price More Price(28)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 20354 Copanlisib ≥98% 1032568-63-0 5mg $61 2024-03-01 Buy
Cayman Chemical 20354 Copanlisib ≥98% 1032568-63-0 1mg $72 2023-06-20 Buy
Cayman Chemical 20354 Copanlisib ≥98% 1032568-63-0 10mg $91 2024-03-01 Buy
TRC B119060 BAY80-6946 1032568-63-0 10mg $395 2021-12-16 Buy
ChemScene CS-0741 Copanlisib 98.91% 1032568-63-0 100mg $450 2021-12-16 Buy
Product number Packaging Price Buy
20354 5mg $61 Buy
20354 1mg $72 Buy
20354 10mg $91 Buy
B119060 10mg $395 Buy
CS-0741 100mg $450 Buy

BAY 80-6946 (Copanlisib) Chemical Properties,Uses,Production

Binding Mode

As shown in the co-crystal structure of copanlisib bound to PI3Kγ, the inhibitor binds with only one critical hydrogen bond to the amide NH of Val882 in the adenine pocket, employing the imidazoline N1 nitrogen (Figs. 1 and 2). In addition, the C5 aminopyrimidine group fills the affinity pocket, forming hydrogen bonds with two carboxylic residues of Asp836 and Asp841 through the amino group. Finally, the solvent exposed morpholine lies over Trp812, presumably providing additional attractive molecular contacts.
Figure 1. X-ray crystal structure of copanlisib bound  to PI3Kγ (PDB ID: 5G2N).Figure 2. Summary of copanlisib–PI3Kγ interactions  based on a co-crystal structure.

Uses

BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft models.

Definition

ChEBI: Copanlisib is an imidazoquinazoline that is 2,3-dihydroimidazo[1,2-c]quinazoline substituted by (2-aminopyrimidine-5-carbonyl)amino, methoxy, and 3-(morpholin-4-yl)propoxy groups at positions 5, 7 and 8, respectively. It is a intravenous pan-class I PI3K inhibitor used for the treatment of relapsed follicular lymphoma in patients who have received at least 2 prior systemic therapies. It has a role as an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor, an antineoplastic agent and an apoptosis inducer. It is a member of morpholines, an aromatic ether, a diether, a tertiary amino compound, a secondary carboxamide, a pyrimidinecarboxamide, an aminopyrimidine and an imidazoquinazoline.

brand name

Aliqopa

General Description

Class: lipid kinase; Treatment: FL (IV infusion); Other name: BAY 80-6946; Elimination half-life = 52 h (IV); Protein binding = 84.2%

Pharmacokinetics

Copanlisib has poor oral bioavailability due to low permeability and poor solubility, and therefore, it is not suitable for an oral medication. Consequently, it was developed as an IV drug. IV infusion of copanlisib resulted in rapid distribution throughout the body and a prolonged elimination half-life (52 h).

target

pan-PI3K

Metabolism

Copanlisib was the predominant component in human plasma, accounting for 84% of total radioactivity AUC, and the morpholinone metabolite 6 was the only circulating metabolite (about 5%).
Metabolic pathway of copanlisib in humans.

BAY 80-6946 (Copanlisib) Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 148)Suppliers
Supplier Tel Email Country ProdList Advantage
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512 info@tianfuchem.com China 21687 55
Nanjing ChemLin Chemical Industry Co., Ltd.
025-83697070 product@chemlin.com.cn CHINA 3012 60
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32715 60
career henan chemical co
+86-0371-86658258 sales@coreychem.com China 29914 58
Biochempartner
0086-13720134139 candy@biochempartner.com CHINA 967 58
Hubei xin bonus chemical co. LTD
86-13657291602 linda@hubeijusheng.com CHINA 22968 58
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19553 58
Chongqing Chemdad Co., Ltd
+86-023-6139-8061 +86-86-13650506873 sales@chemdad.com China 39916 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6313 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 27690 58

View Lastest Price from BAY 80-6946 (Copanlisib) manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
BAY 80-6946 (Copanlisib) pictures 2019-07-06 BAY 80-6946 (Copanlisib)
1032568-63-0
US $2.00 / kg 1kg 99% 100kg Career Henan Chemical Co

BAY 80-6946 (Copanlisib) Spectrum

2-Amino-N-[2,3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1,2-c]quinazolin-5-yl]-5-pyrimidinecarboxamide 5-Pyrimidinecarboxamide, 2-amino-N-[2,3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1,2-c]quinazolin-5-yl]- Copanlisib(BAY80-6946) BAY 80-6946 (Copanlisib) 7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine Aliqopa) BAY 80-6946 (Copanlisib) USP/EP/BP Copanlisib free base BAY 80-6946; BAY80-6946; BAY-80-6946; BAY806946; BAY-806946; BAY 806946; COPANLISIB FREE BASE CS-2321 BAY 80-6946 (BAY80-6946 Copanlisib base Copanlisib, 98%, an ATP-competitive selective class-I PI3 kinases inhibitor BAY80-6946 Copanlisib 2-Amino-N-(7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyrimidine-5-carboxamide 1032568-63-0 C23H28N8O4 Inhibitors Akt mTOR PI3K PI3K/Akt/mTOR